VUNO's First AI-based Prospective Study Results Published in Critical Care
- Written by PR Newswire
SEOUL, South Korea, Sept. 18, 2023 /PRNewswire/ -- VUNO Inc., South Korean medical AI company announced that its AI-based cardiac arrest risk management system, VUNO Med®-DeepCARS™, has proven its clinical validity for the first time through a prospective study utilizing Real World Data(RWD).
VUNO announced that the multicenter clinical...
Read more: VUNO's First AI-based Prospective Study Results Published in Critical Care















